
Opinion|Videos|January 7, 2026
Closing Thoughts from the Experts
This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.
Advertisement
Episodes in this series

An expert pharmacist and physician offer their main takeaways from the recent clinical trial data in TNBC. Clinical pearls for pharmacists are offered that will help prepare them for potential approval of these pharmacotherapies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
2
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
3
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
4
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
5

















































































































